Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Business Wire•03/08/2026•16:30 ET

0

Whiz Insights

Get started

Create a free account to read the full story.

Already have an account? Log in

Forgot password?